GLP-1 Agonists: The Complete Guide

GLP-1 (glucagon-like peptide-1) is an incretin hormone your gut releases after meals. It slows gastric emptying, increases insulin in a glucose-dependent way, lowers glucagon, and reduces appetite via brain pathways. Drug versions last hours to a week instead of minutes.

Names you will see: semaglutide (Ozempic for type 2 diabetes, Wegovy for chronic weight management), liraglutide (daily), and tirzepatide (Mounjaro / Zepbound), which also agonizes GIP. Newer multi-agonists are in the pipeline. The category is moving faster than most supplement trends.

Biohacking interest is obvious: appetite, glucose, inflammation, and visceral fat all sit in the same conversation as CGMs, berberine, and fasting. The difference is potency. These drugs outperform lifestyle-only averages in trials — and they create new failure modes if you treat them like caffeine.

Weight and metabolism: STEP (semaglutide) and SURMOUNT (tirzepatide) randomized trials showed double-digit percentage body-weight reductions versus placebo on top of lifestyle counseling, with improvements in glycemic markers. Cardiovascular outcome data for some agents (e.g., SELECT for semaglutide in people with overweight/obesity and CVD) pushed the class beyond 'vanity fat loss.'

Lean mass: when people lose a lot of weight quickly, some of it is muscle. Trial DEXA sub-studies and clinic experience both say resistance training and high protein are not optional extras. This is why we now treat GLP-1s and strength training as a paired topic.

Brain and reward: many users describe food noise going quiet. That is a feature for obesity care and a watch-item if appetite drops so far that protein and micronutrients collapse.

The only legitimate protocol is the one on the label plus your prescriber's titration. Doses escalate slowly to limit nausea. Missed-dose rules and contraindications (including personal/family medullary thyroid carcinoma and MEN2 for the boxed warning class) are clinician territory.

The biohacking layer that is actually yours: lift 2–4 days per week, hit protein (many obesity clinicians now target the high end of 1.6–2.2g/kg of goal or current lean mass — individualize), wear a CGM if you want feedback, and do not celebrate a scale drop that came from skipped meals and no iron.

Sourcing: FDA-approved pens from a licensed pharmacy. Compounded copies exploded during shortages and created dose-confusion and contamination stories. 'Research peptide' GLP-1s are not a longevity hack.

Weeks 1–4: fullness, smaller portions, possible nausea, constipation, or reflux. Eating slower and stopping at comfortable fullness matters more than a fasting window.

Months 2–6: the steep part of the weight curve for many trial participants. This is when muscle loss becomes visible if you only cut calories.

After stopping: weight regain is common unless habits (protein, lifting, sleep, food environment) changed. Some people stay on a maintenance dose; that is a medical plan, not a Reddit taper.

Common: nausea, vomiting, diarrhea or constipation, fatigue. Less common but important: gallbladder disease, dehydration/kidney stress from vomiting, and rare pancreatitis signals (severe abdominal pain — seek care).

Boxed warning class effects and pregnancy: these drugs are not casual fertility-era experiments. Discuss contraception and surgical timing (delayed gastric emptying affects anesthesia) with your physician.

Cost and access: list prices are high; insurance coverage is uneven and changing. That economic pressure is exactly why grey-market sellers showed up. Pay the boring pharmacy price or do not start.

r/Biohackers split into three camps: 'this is the most important metabolic tool of the decade,' 'it is cheating and you will rebound,' and 'fine if you lift and eat protein.' The third camp matches the evidence we have.

Attia-style commentary focuses on adipose tissue as a disease driver and on not sacrificing skeletal muscle. Berberine remains a modest OTC glucose tool; it is not a GLP-1. Do not swap a prescription for a bitter capsule without a doctor.